Sideroblastic anemia medical therapy: Difference between revisions
Jump to navigation
Jump to search
Nazia Fuad (talk | contribs) No edit summary |
Nazia Fuad (talk | contribs) |
||
| Line 10: | Line 10: | ||
=== Non pharmacologic and general measures === | === Non pharmacologic and general measures === | ||
The following measures are used to treat sideoblastic anemia.<ref name="pmid24003969">{{cite journal |vauthors=Fujiwara T, Harigae H |title=Pathophysiology and genetic mutations in congenital sideroblastic anemia |journal=Pediatr Int |volume=55 |issue=6 |pages=675–9 |date=December 2013 |pmid=24003969 |doi=10.1111/ped.12217 |url=}}</ref> | The following measures are used to treat sideoblastic anemia.<ref name="pmid24003969">{{cite journal |vauthors=Fujiwara T, Harigae H |title=Pathophysiology and genetic mutations in congenital sideroblastic anemia |journal=Pediatr Int |volume=55 |issue=6 |pages=675–9 |date=December 2013 |pmid=24003969 |doi=10.1111/ped.12217 |url=}}</ref><ref name="pmid4691061">{{cite journal |vauthors=Mason DY, Emerson PM |title=Primary acquired sideroblastic anaemia: response to treatment with pyridoxal-5-phosphate |journal=Br Med J |volume=1 |issue=5850 |pages=389–90 |date=February 1973 |pmid=4691061 |pmc=1588335 |doi= |url=}}</ref> | ||
* Avoid [[alcohol]] | * Avoid [[alcohol]] | ||
* Avoid [[zinc]] supplements | * Avoid [[zinc]] supplements | ||
| Line 23: | Line 23: | ||
=== Pharmacologic measures === | === Pharmacologic measures === | ||
* Medications are used to control, [[anemia]], [[morbidity]] and complications. | * Medications are used to control, [[anemia]], [[morbidity]] and complications.<ref name="pmid4691061" /> | ||
* The two groups are | * The two groups are | ||
** [[Vitamins]] | ** [[Vitamins]] | ||
Revision as of 19:40, 13 August 2018
|
Sideroblastic anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sideroblastic anemia medical therapy On the Web |
|
American Roentgen Ray Society Images of Sideroblastic anemia medical therapy |
|
Risk calculators and risk factors for Sideroblastic anemia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nazia Fuad M.D.
Overview
The medical therapy for sideroblastic anemia include pyridoxine, thiamine and follic acid. For iron overload iron chelators are used.
Medical Therapy
Non pharmacologic and general measures
The following measures are used to treat sideoblastic anemia.[1][2]
- Avoid alcohol
- Avoid zinc supplements
- Remove toxic agents
- Lead
- Drugs
- With isoniazid, pyridoxine is given to reverse its adverse effect on heme synthesis.
- Blood transfusion
Pharmacologic measures
Vitamins
- Preffered regimen: Adults 0.4mg, PO,once daily
- preffered regimen peadiatric: 1 mg/day IV/PO/IM/SC initially, then 0.1-0.4 mg/day
- Pyridoxine
- Thiamine
- Preffered regimen:adults 50mg,PO,once daily
- Preffered regimen(1) peadiatric 10-25 mg IV/IM qDay
- Preffered regimen(2) peadiatric10-50 mg PO qDay for 2 weeks,
- Then 5-10 mg/day PO for 1 month
Iron chelators
- Used in patietns having iron overload to remove toxic iron from tissues.
- Preffered rgimen(1) adults Desferal 0.5-1g QD ,I/M
- Preffered rgimen(2) adults Desferal 20-40mg/kg/day SC over 8-24 hours with portable pump providing continuous mini-infusion
- Preffered rgimen(1) peadiatric DesferalSC 1-2g (20-40mg/kg/day) SC over 8-24 hours by small portable pump
- Preffered rgimen(2) peadiatric Desferal IV, 40-50mg/kg/day over 8-12 hours for 5-7 days/ week,maximum, < 60mg/kg/day and an IV infusion rate of <15mg/kg/hr)
References
- ↑ Fujiwara T, Harigae H (December 2013). "Pathophysiology and genetic mutations in congenital sideroblastic anemia". Pediatr Int. 55 (6): 675–9. doi:10.1111/ped.12217. PMID 24003969.
- ↑ 2.0 2.1 Mason DY, Emerson PM (February 1973). "Primary acquired sideroblastic anaemia: response to treatment with pyridoxal-5-phosphate". Br Med J. 1 (5850): 389–90. PMC 1588335. PMID 4691061.